Share on StockTwits

Analysts at Canaccord Genuity increased their price target on shares of Theratechnologies (NASDAQ:THER) from C$0.50 to C$0.60 in a research report issued to clients and investors on Thursday.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.